These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 15887051)

  • 21. Sentinel lymph node biopsy for melanoma: a critical update for dermatologists after two decades of experience.
    Ross MI; Gershenwald JE
    Clin Dermatol; 2013; 31(3):298-310. PubMed ID: 23608449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sentinel lymph node biopsy has no benefit for patients with primary cutaneous melanoma metastatic to a lymph node: an assertion based on comprehensive, critical analysis: part I.
    Medalie NS; Ackerman AB
    Am J Dermatopathol; 2003 Oct; 25(5):399-417. PubMed ID: 14501289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on the use of sentinel node biopsy in patients with melanoma: who and how.
    Chao C; McMasters KM
    Curr Opin Oncol; 2002 Mar; 14(2):217-20. PubMed ID: 11880714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sentinel node biopsy versus elective lymph node dissection in patients with cutaneous melanoma in a Japanese population.
    Tsutsumida A; Furukawa H; Yamamoto Y; Horiuchi K; Yoshida T; Minakawa H; Fujii S; Murao N; Kuwahara H; Minamimoto T; Fujioka H; Sakamoto T; Honma T
    Int J Clin Oncol; 2007 Aug; 12(4):245-9. PubMed ID: 17701001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sentinel lymph node biopsy and melanoma: 2010 update Part I.
    Stebbins WG; Garibyan L; Sober AJ
    J Am Acad Dermatol; 2010 May; 62(5):723-34; quiz 735-6. PubMed ID: 20398810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of disease free survival in cutaneous melanoma patients subject to sentinel lymph node biopsy.
    Łobaziewicz W; Szloch J; Wajda J; Legkiy O; Marczyk E; Wysocki W
    Pol Przegl Chir; 2020 Mar; 92(3):15-21. PubMed ID: 32759393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sentinel lymph node biopsy in patients with Stage I/II melanoma: Clinical experience and literature review.
    Gipponi M; Di Somma C; Peressini A; Solari N; Gliori S; Nicolo G; Schenone F; Queirolo P; Sertoli MR; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):133-40. PubMed ID: 14991885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma.
    van Akkooi AC; de Wilt JH; Verhoef C; Graveland WJ; van Geel AN; Kliffen M; Eggermont AM
    Eur J Cancer; 2006 Feb; 42(3):372-80. PubMed ID: 16403622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of immunohistochemistry on sentinel node biopsy for primary cutaneous malignant melanoma.
    Ross GL; Shoaib T; Scott J; Camilleri IG; Gray HW; MacKie R; Soutar DS
    Br J Plast Surg; 2003 Mar; 56(2):153-5. PubMed ID: 12791361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sentinel node biopsy in malignant melanoma: Swedish experiences 1997-2005.
    Mattsson J; Bergkvist L; Abdiu A; Aili Low JF; Naredi P; Ullberg K; Garpered U; Håkansson A; Ingvar C
    Acta Oncol; 2008; 47(8):1519-25. PubMed ID: 18941953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathology of melanocytic lesions: new, controversial, and clinically important issues.
    Scolyer RA; Thompson JF; Stretch JR; Sharma R; McCarthy SW
    J Surg Oncol; 2004 Jul; 86(4):200-11. PubMed ID: 15221927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sentinel lymph node biopsy in cutaneous melanoma.
    Ribero S; Sportoletti Baduel E; Osella-Abate S; Dika E; Quaglino P; Picciotto F; Macripò G; Bataille V
    G Ital Dermatol Venereol; 2017 Aug; 152(4):355-359. PubMed ID: 27248147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sentinel lymph node biopsy from the vantage point of an oncologic surgeon.
    Wilson LL
    Clin Dermatol; 2009; 27(6):594-6. PubMed ID: 19880046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathologic analysis of sentinel lymph nodes in melanoma patients: current and future trends.
    Roberts AA; Cochran AJ
    J Surg Oncol; 2004 Mar; 85(3):152-61. PubMed ID: 14991887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sentinel lymph node dissection in primary melanoma reduces subsequent regional lymph node metastasis as well as distant metastasis after nodal involvement.
    Leiter U; Buettner PG; Bohnenberger K; Eigentler T; Meier F; Moehrle M; Breuninger H; Garbe C
    Ann Surg Oncol; 2010 Jan; 17(1):129-37. PubMed ID: 19866238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Impact of sentinel lymph node biopsy on the treatment of melanoma].
    Santinami M; Baldi M; Tragni G; Maurichi A; Moglia D; Bono A; Bartoli C; Patuzzo R; Pennacchioli E; Cascinelli N
    Tumori; 2003; 89(4 Suppl):273-5. PubMed ID: 12903619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cutaneous melanoma and sentinel lymph node biopsy: where are we today?].
    Girod A; Salmon R; Rodriguez J
    Bull Cancer; 2007 Jul; 94(7):687-91. PubMed ID: 17723951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathobiology of the sentinel node.
    Cochran AJ; Ohsie SJ; Binder SW
    Curr Opin Oncol; 2008 Mar; 20(2):190-5. PubMed ID: 18300769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
    Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
    Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sentinel lymph node biopsy in cutaneous melanoma: outcome after 5-years follow-up.
    Cuchet E; Pinel N; Corcella D; Vuillez JP; Lebeau J; Moutet F; Colonna M; Leccia MT
    Eur J Dermatol; 2007; 17(5):387-91. PubMed ID: 17673381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.